A triple crosslinked micelle-hydrogel lacrimal implant for localized and prolonged therapy of glaucoma

In conclusion, the triple crosslinked micelle-hydrogel lacrimal implant could effectively lower the IOP with splendid compatibility, demonstrating the promising prospect in the long-term noninvasive treatment of glaucoma.PMID:36841507 | DOI:10.1016/j.ejpb.2023.02.011

Source: European Journal of Pharmaceutics and Biopharmaceutics - February 25, 2023 Category: Drugs & Pharmacology Authors: Jingyi Zhao Jian Xiong Yun Ning Jiansong Zhao Zhipeng Wang Linhui Long Haibing He Jingxing Gou Tian Yin Xing Tang Yu Zhang Source Type: research